• en
  • fr

  • Innovation and Research & Development

    Speeding Up and Enhancing Diagnostics

    Our R&D teams are also working to further advance the speed and performance of our existing platforms.

    One such project is the new technology being developed for the VITEK® 2 Identification and Susceptibility System. Research teams are working to extend the existing menu of VITEK® 2 cards, and in particular, to enhance the detection of resistance to carbapenems mediated by enzymes or other mechanisms. Carbapenems are some of the last-line antibiotics today to treat multi-drug resistant infections. In other work, through the use of new technologies such as enhanced optical imaging, antibiotic susceptibility results may be accelerated to provide highly accurate results within a few hours.

    These state-of-the-art and innovative enhancements will deliver additional medically relevant information, increased accuracy of results and the availability of same-day test reports, helping to fight antibiotic resistance by guiding targeted antibiotic treatment to patients earlier and more efficiently.

    Illustration_Chap7-3a.png

    The viability of E. coli can be determined by fluorescent labeling.

    Photo credit : Quentin Josso, bioMérieux